MarketCap
Facebook
X
Telegram
Immunovant ROA Ratio | IMVT
Annual ROA Ratio Immunovant
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -52.83 | -53.31 | -38.92 | -51.98 | -30.4 | -26.04 | -60.69 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -26.04 | -60.69 | -44.88 |
Quarterly ROA Ratio Immunovant
| 2027-Q2 | 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.97 | -68.42 | -50.45 | -64.16 | -80.05 | -76.58 | -73.13 | -70.72 | -51.54 | -53.39 | -59.67 | -63.01 | -69.64 | -60.75 | -48.5 | -46.12 | -43.45 | -39.88 | -38.42 | -34.0 | -22.81 | -22.81 | -30.66 | -30.75 | -30.41 | -29.72 | -31.07 | -33.69 | -38.98 | -48.91 | -39.71 | -2214.32 | -3280.54 | -0.0 | -2184.94 | - | -1078.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.0 | -3280.54 | -285.35 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Kiromic BioPharma
KRBP
|
-314.78 | - | 6.61 % | $ 3.08 M |  USA |
 |
Nektar Therapeutics
NKTR
|
-58.51 | $ 38.41 | 1.67 % | $ 648 M | USA |
 |
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
CorMedix
CRMD
|
19.74 | $ 5.31 | -2.23 % | $ 383 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-25.67 | $ 45.39 | 0.53 % | $ 4.08 B |  Schweiz |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
-12.01 | $ 1.66 | -2.64 % | $ 1.12 B |  Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
-23.1 | - | -23.04 % | $ 26.6 M | USA |
 |
Tyme Technologies
TYME
|
-26.84 | - | 8.07 % | $ 54 M | USA |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Verona Pharma plc
VRNA
|
-36.57 | - | - | $ 69.7 B |  Britain |
 |
Oramed Pharmaceuticals
ORMP
|
27.74 | $ 4.1 | 3.27 % | $ 170 M | Israel |
 |
Corner Growth Acquisition Corp.
COOL
|
-16.34 | - | -0.89 % | $ 114 M | USA |
 |
Karuna Therapeutics
KRTX
|
-32.46 | - | - | $ 12.2 B | USA |
 |
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | USA |
 |
Curis
CRIS
|
-37.97 | $ 0.59 | -9.62 % | $ 7.77 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
-37.35 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Fusion Pharmaceuticals
FUSN
|
-33.2 | - | - | $ 1.41 B |  Canada |
 |
Завод ДИОД
DIOD
|
2.66 | - | - | - |  Russia |
 |
Gritstone Oncology
GRTS
|
-77.9 | - | 0.42 % | $ 213 M | USA |
 |
Pfizer
PFE
|
3.73 | $ 29.42 | 0.19 % | $ 167 B | USA |
 |
HOOKIPA Pharma
HOOK
|
-52.7 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
1.33 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
4.27 | - | - | $ 109 M | USA |
|
Monopar Therapeutics
MNPR
|
-9.75 | $ 71.83 | 0.07 % | $ 532 M | USA |
 |
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
-53.52 | - | -1.96 % | $ 4.68 M | USA |
 |
Prothena Corporation plc
PRTA
|
-74.69 | $ 8.74 | 2.1 % | $ 470 M | USA |
 |
Exelixis
EXEL
|
27.51 | $ 70.73 | 0.21 % | $ 19.2 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-206.68 | - | 17.91 % | $ 11.1 M | USA |
 |
Фармсинтез
LIFE
|
-25.57 | - | - | - | Russia |
 |
Arcus Biosciences
RCUS
|
-30.99 | $ 18.83 | 0.86 % | $ 2.02 B | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
11.61 | $ 14.79 | -0.57 % | $ 12.3 B |  India |
 |
Oncternal Therapeutics
ONCT
|
-107.49 | - | -24.12 % | $ 1.56 M | USA |
 |
Iterum Therapeutics
ITRM
|
-55.55 | - | - | $ 591 K |  Irlanda |
 |
Royalty Pharma plc
RPRX
|
3.93 | $ 70.01 | 0.81 % | $ 30.1 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
-0.04 | $ 114.06 | 0.1 % | $ 7.41 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | USA |
 |
SIGA Technologies
SIGA
|
10.61 | $ 3.17 | 0.32 % | $ 227 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
-48.42 | - | - | $ 401 M | USA |
 |
ImmunoGen
IMGN
|
-63.89 | - | - | $ 7.92 B | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
-57.64 | - | -8.77 % | $ 12.4 M | Israel |
 |
Histogen
HSTO
|
-55.81 | - | 31.6 % | $ 2.12 M | USA |
 |
Summit Therapeutics
SMMT
|
-143.72 | $ 16.64 | -6.7 % | $ 12.4 B | Britain |
 |
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | USA |
 |
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | USA |
 |
Syndax Pharmaceuticals
SNDX
|
-53.88 | $ 9.59 | 1.05 % | $ 831 M | USA |
 |
Scholar Rock Holding Corporation
SRRK
|
-93.5 | $ 46.66 | -2.8 % | $ 5.35 B | USA |
 |
Clovis Oncology
CLVS
|
-13.62 | - | -7.23 % | $ 13 M | USA |
|
Protara Therapeutics
TARA
|
-27.4 | $ 2.61 | 7.41 % | $ 112 M | USA |